Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. [electronic resource]
Producer: 20140103Description: 935-40.e1 p. digitalISSN:- 1097-6744
- Aged
- Atrial Fibrillation -- complications
- Blood Glucose -- analysis
- Cyclohexanes -- therapeutic use
- Diabetes Mellitus, Type 2 -- complications
- Double-Blind Method
- Female
- Glucose Intolerance -- blood
- Humans
- Hypoglycemic Agents -- therapeutic use
- Incidence
- Male
- Middle Aged
- Nateglinide
- Outcome Assessment, Health Care
- Phenylalanine -- analogs & derivatives
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Tetrazoles -- therapeutic use
- Valine -- analogs & derivatives
- Valsartan
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.